Phillips 66
PSXPhillips 66's earnings have outrun its stock. EPS grew +116.2% in a year against a +72.1% price move.
The sharpest disagreement: annual EPS moved +116.2% against a +72.1% price move — the market has not yet caught up with the delivery.
The price is in a confirmed uptrend (34 weeks in) while the P/E sits at the 76th percentile of its own 4-year range. Underneath, the last four quarters read improving — profit −58.5% year on year, and 116% of the last 3 years' profit arrived as cash. What settles it: whether the price catches up with earnings that have already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Phillips 66 trades at $206, in a confirmed uptrend and 34 weeks into that stage. That is +28.0% against its own 200-day average. It sits at 93% of a 52-week range of $124 to $212. On relative strength it has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks.
Today the stock is in a confirmed uptrend — week 34 of stage 2. At $206 it trades +28.0% versus its 200-day average and sits at 93% of its 52-week range ($124–$212).
Against the market, two honest reads. Cumulative: over the last 10.1 years the stock moved +175% while the S&P 500 moved +263% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 5 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
Phillips 66 trades at 20.3× P/E, at the pricey end of its own range (76th percentile). Its long-run median P/E is 12.0×, measured across 4.3 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 20.3× is at the pricey end of its own range (76th percentile), against a long-run median of 12.0× measured over 4.3 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year annual EPS moved +116.2% against a +72.1% price move — earnings outran the price, pushing the multiple DOWN its own range.
The price move, decomposed: over 3y, of the +23.1%/yr price move, ~−23.9%/yr came from earnings growth and ~+47.0 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: Turning around Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Phillips 66 reads as turning around on its fundamental arc. Turning around — profit growth swung from −67.0% at the trough to +116.9%, a 4-quarter improving streak, ROCE holding at 1.2%. The read is built from 12 quarters across 4 curves, on full evidence.
Why it matters: growth inflections are where re-ratings start — the curves say a turn is forming, so the question becomes whether the next quarters confirm it.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −7.5% | −8.0% | — | — |
| Profit | +108.8% | −26.5% | — | — |
| EPS | +116.2% | −22.6% | — | — |
| Stock price | +72.1% | +23.1% | +22.7% | +10.2% |
4-Factor Sector Score
49.0/100 — rank 9 of 16 in Oil & Gas Refining & Marketing · 58% evidence confidence
Phillips 66 scores 49.0 out of 100 against the 16 companies it is compared with in Oil & Gas Refining & Marketing, ranking 9. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 17.5 + 8.7 + 9.4 + 13.4 = 49. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Phillips 66 reported $32.5 B of revenue in the Mar 26 quarter, +6.9% year on year. That is the 2nd straight quarter of year-on-year growth. Over 4 years it has compounded at 4.4% a year. The last full year, FY25, came in at $132 B. The last four reported quarters add to $134 B.
FY25 revenue came in at $132 B (−7.5% on the year), capping 4 years at 4.4% compound. The latest quarter (Mar 26) printed $32.5 B, +6.9% year on year — the 2nd consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged −1.8% growth against the decade's 4.4% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −2.4% over the last 4 quarters against −4.9%/yr over the last 8 — stabilising; TTM profit +116.9% vs −15.4%/yr — accelerating.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
Phillips 66's operating margin is 0.3% in the Mar 26 quarter, +1.7 percentage points against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −0.9% to 5.6%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.3%, +1.7 pp against the same quarter a year ago. Across 5 fiscal years the operating margin has ranged −0.9%–5.6%.
Why the margin moved: operating margin went +1.7 pp year on year while gross margin went +1.1 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Phillips 66 earned $0.2 B of net profit in the Mar 26 quarter, −58.5% year on year. Full-year FY25 profit was $4.5 B. The 4-year compound rate is 29.9%. That is 0.7% of the quarter's revenue. The same quarter a year earlier earned $0.5 B.
Mar 26 profit was $0.2 B, −58.5% year on year. On the full year, FY25 printed $4.5 B (+108.8%), and the 4-year compound rate is 29.9%.
🚨 Why profit moved: revenue contributed +6.9% and the margin +1.7 pp — the quarter was revenue-led, with the margin roughly flat.
Pace comparison, last four quarters: profit +2,385.8% vs revenue −1.8%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra dollar of revenue drops more to the bottom line.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 116% of Phillips 66's reported profit arrived as operating cash — the cash follows the profit. In FY25 that was $5.0 B of operating cash against $4.5 B of profit. After $2.2 B of capital spending, $2.7 B was left as free cash.
FY25: operating cash of $5.0 B against reported profit of $4.5 B, leaving free cash of $2.7 B after $2.2 B of capital spending. Across the last 3 fiscal years the conversion rate is 116% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Why: conversion is measured cleanly, but the working-capital day-counts behind it sit below what we hold — the move is shown without inventing its driver.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Phillips 66 does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $6.0 B over the last 3 years. Averaged over those years that is 1.5% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $6.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
Phillips 66 earns a ROE of 15% in FY25. That is up from a trough of 7% in FY21. Return on invested capital clears the cost of that capital by +0.9 percentage points, so growth here adds value rather than only size. The wiring behind it is 3.4% net margin on 1.80× asset turns.
FY25 ROE is 15%, recovered from a FY21 trough of 7% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 3.4% net margin × 1.80× asset turns × 2.44× balance-sheet leverage ≈ 14.9% on equity. Margin does its share; leverage is a meaningful part of the equation.
The capstone test — ROIC − WACC: 7.8% − 6.9% = a +0.9 pp spread. The 6.9% is an estimate of this company's own cost of capital — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Phillips 66 paid $4.87 per share over the last four reported quarters, up 10.4% on a year ago. The most recent declaration was $1.27 for Mar 26. Against the current price of $206 that is a trailing yield of 2.37%, measured on dividends already paid rather than on a forecast.
Phillips 66 paid $4.87 per share across the last four reported quarters, most recently $1.27 for Mar 26. That is up 10.4% against the same quarter a year earlier. Against the current price of $206 the trailing twelve months work out to 2.37% — trailing dividends measured against today's price, not a forward estimate.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.
Phillips 66 carries total debt of $27.1 B against shareholder equity of $29.7 B as of Mar 26, a debt-to-equity of 0.91. On the annual view that ratio went from 0.67 in FY21 to 0.65 in FY25. Read the returns elsewhere on this page with that leverage in mind.
Mar 26: total debt of $27.1 B against shareholder equity of $29.7 B — a debt-to-equity of 0.91. On the annual view, debt-to-equity went from 0.67 (FY21) to 0.65 (FY25). Read the returns on this page with that leverage in mind.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
2.0% of Phillips 66's tradable float is currently sold short — the crowd is not positioned against this stock. At typical trading volumes those positions would take about 2.6 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
The latest reading: 2.0% of the float is sold short, and at typical trading volumes it would take about 2.6 days to buy those positions back. The crowd is not positioned against this stock. This is a single point-in-time reading — we do not yet hold its history, so we show no trend chart.
Why it sits there: who is doing the shorting, and why, does not travel with the number — the level is shown without inventing its story.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Phillips 66: the Z-score reads 2.97. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits in the grey band between the two. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 2.97 sits in the grey band — neither clearly safe nor clearly distressed.
The safety line in one sentence: the Z-score reads 2.97.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1PBF Energy Inc.PBF | 68.3/100Thin evidence · provisional58% evidence | BREAKING OUT | 23.0/35 Revenue — · PAT — · OPM change 11 pp 45% evidence | 13.8/25 ROCE 12.9% · OPM 3.8% 76% evidence | 11.5/20 P/E 4× · PEG — 15% evidence | 20.0/20 RS sector 36.8% · RS bench 55.3% · 1Y 199.2%6 of 12 weeks ahead 100% evidence |
| Exact sum: 23 + 13.8 + 11.5 + 20 = 68.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 2Valero Energy CorporationVLO | 65.2/100Thin evidence · provisional58% evidence | BREAKING OUT | 23.1/35 Revenue — · PAT — · OPM change 8.3 pp 45% evidence | 15.2/25 ROCE 11.5% · OPM 5.3% 76% evidence | 10.6/20 P/E 10.8× · PEG — 15% evidence | 16.3/20 RS sector 16.7% · RS bench 33.2% · 1Y 131.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 23.1 + 15.2 + 10.6 + 16.3 = 65.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Star Group, L.P.SGU | 61.6/100Mixed-positive evidence75% evidence | BASING | 21.6/35 Revenue 3.2% · PAT 34.3% · OPM change 3.6 pp 83% evidence | 18.8/25 ROCE 22.6% · OPM 20.5% 76% evidence | 16.3/20 P/E 4.2× · PEG 0.09 65% evidence | 4.9/20 RS sector -19.5% · RS bench -6.7% · 1Y 9.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 21.6 + 18.8 + 16.3 + 4.9 = 61.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Marathon Petroleum CorporationMPC | 60.1/100Mixed-positive evidence81% evidence | BREAKING OUT | 20.5/35 Revenue -1.7% · PAT 55.6% · OPM change 1.9 pp 83% evidence | 10.9/25 ROCE 2.3% · OPM 4.1% 76% evidence | 12.7/20 P/E 15.9× · PEG 0.36 65% evidence | 16.0/20 RS sector 13.9% · RS bench 30.3% · 1Y 94.4%8 of 12 weeks ahead 100% evidence |
| Exact sum: 20.5 + 10.9 + 12.7 + 16 = 60.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 5HF Sinclair CorporationDINO | 59.9/100Thin evidence · provisional58% evidence | BREAKING OUT | 21.6/35 Revenue — · PAT — · OPM change 10.6 pp 45% evidence | 13.0/25 ROCE 8% · OPM 11.9% 76% evidence | 11.0/20 P/E 6.6× · PEG — 15% evidence | 14.3/20 RS sector 17.1% · RS bench 34.1% · 1Y 102.6%10 of 12 weeks ahead 100% evidence |
| Exact sum: 21.6 + 13 + 11 + 14.3 = 59.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 6Sunoco LPSUN | 55.7/100Mixed-positive evidence81% evidence | TURNING | 21.1/35 Revenue 37.3% · PAT 13.3% · OPM change 2.4 pp 83% evidence | 13.6/25 ROCE 4.5% · OPM 8.1% 76% evidence | 12.1/20 P/E 14.3× · PEG 0.63 65% evidence | 8.9/20 RS sector -3.2% · RS bench 11.3% · 1Y 42.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 21.1 + 13.6 + 12.1 + 8.9 = 55.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 7Par Pacific Holdings, Inc.PARR | 55.0/100Mixed-positive evidence64% evidence | TURNING | 18.7/35 Revenue -2.5% · PAT — · OPM change 4.5 pp 62% evidence | 9.1/25 ROCE 2.3% · OPM 3.6% 76% evidence | 10.8/20 P/E 7× · PEG — 15% evidence | 16.4/20 RS sector 35.2% · RS bench 53.3% · 1Y 204%6 of 12 weeks ahead 100% evidence |
| Exact sum: 18.7 + 9.1 + 10.8 + 16.4 = 55 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8World Kinect CorporationWKC | 52.0/100Thin evidence · provisional52% evidence | BREAKING OUT | 20.2/35 Revenue — · PAT — · OPM change 0.7 pp 45% evidence | 10.0/25 ROCE 3.5% · OPM 0.6% 76% evidence | 8.7/20 P/E 118.2× · PEG — 15% evidence | 13.1/20 RS sector 11.8% · RS bench 29.1% · 1Y 53.8%12 of 12 weeks ahead 70% evidence |
| Exact sum: 20.2 + 10 + 8.7 + 13.1 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Phillips 66this pagePSX | 49.0/100Thin evidence · provisional58% evidence | BREAKING OUT | 17.5/35 Revenue — · PAT — · OPM change 1.7 pp 45% evidence | 8.7/25 ROCE 0.2% · OPM 0.3% 76% evidence | 9.4/20 P/E 17.9× · PEG — 15% evidence | 13.4/20 RS sector 3.6% · RS bench 18.8% · 1Y 72.8%6 of 12 weeks ahead 100% evidence |
| Exact sum: 17.5 + 8.7 + 9.4 + 13.4 = 49 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 10CrossAmerica Partners LPCAPL | 43.0/100Mixed-negative evidence74% evidence | BASING | 16.8/35 Revenue -9.4% · PAT 81.8% · OPM change 2.6 pp 62% evidence | 10.0/25 ROCE 2.7% · OPM 2.8% 76% evidence | 14.3/20 P/E 13.9× · PEG 0.32 65% evidence | 1.9/20 RS sector -22.3% · RS bench -9.9% · 1Y 5.7%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.8 + 10 + 14.3 + 1.9 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Delek Logistics Partners, LPDKL | 40.8/100Mixed-negative evidence81% evidence | TURNING | 14.8/35 Revenue 12.9% · PAT 14.1% · OPM change -5.6 pp 83% evidence | 11.6/25 ROCE 1.7% · OPM 13.4% 76% evidence | 5.4/20 P/E 15.7× · PEG 2.77 65% evidence | 9.0/20 RS sector -7.9% · RS bench 6.2% · 1Y 33.6%4 of 12 weeks ahead 100% evidence |
| Exact sum: 14.8 + 11.6 + 5.4 + 9 = 40.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12CVR Energy, Inc.CVI | 39.9/100Thin evidence · provisional58% evidence | ASLEEP | 18.9/35 Revenue — · PAT — · OPM change 0.7 pp 45% evidence | 8.8/25 ROCE 2.8% · OPM -7.3% 76% evidence | 9.2/20 P/E 40.5× · PEG — 15% evidence | 3.0/20 RS sector -15.9% · RS bench -2.8% · 1Y 28.1%4 of 12 weeks ahead 100% evidence |
| Exact sum: 18.9 + 8.8 + 9.2 + 3 = 39.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 13Clean Energy Fuels Corp.CLNE | 39.8/100Thin evidence · provisional55% evidence | ASLEEP | 22.3/35 Revenue 5.5% · PAT — · OPM change 119.2 pp 62% evidence | 4.5/25 ROCE -0.3% · OPM -2.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -37.9% · RS bench -27.8% · 1Y -18.3%0 of 12 weeks ahead 70% evidence |
| Exact sum: 22.3 + 4.5 + 10 + 3 = 39.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 14Delek US Holdings, Inc.DK | 39.2/100Mixed-negative evidence64% evidence | BREAKING OUT | 8.2/35 Revenue -5.6% · PAT — · OPM change -2 pp 62% evidence | 3.7/25 ROCE -4.3% · OPM -6.8% 76% evidence | 9.0/20 P/E 86× · PEG — 15% evidence | 18.3/20 RS sector 32.4% · RS bench 50.7% · 1Y 220.6%7 of 12 weeks ahead 100% evidence |
| Exact sum: 8.2 + 3.7 + 9 + 18.3 = 39.2 · Decision use: Price leads the evidence: RS versus the benchmark is 50.7%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 15Icahn Enterprises L.P.IEP | 30.5/100Adverse evidence64% evidence | BASING | 16.4/35 Revenue 6.2% · PAT — · OPM change 5.8 pp 62% evidence | 3.7/25 ROCE -4.2% · OPM -21.9% 76% evidence | 8.5/20 P/E 277.5× · PEG — 15% evidence | 1.9/20 RS sector -24.9% · RS bench -12.6% · 1Y -16.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 16.4 + 3.7 + 8.5 + 1.9 = 30.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16ARKO Petroleum Corp.APC | 48.2/100Thin evidence · provisional33% evidence | TURNING | 15.7/35 Revenue — · PAT — · OPM change 0.3 pp 39% evidence | 12.5/25 ROCE 3.6% · OPM 1.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 10.0/20 RS sector — · RS bench — · 1Y —2 of 12 weeks ahead 0% evidence |
| Exact sum: 15.7 + 12.5 + 10 + 10 = 48.2 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Phillips 66's stock price today?
Phillips 66 trades at $206, +72.1% over the past year. The company is valued at $83.0 B. The stock sits at 93% of its 52-week range of $124–$212, +28.0% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 34 weeks in. — as of 5 August 2026.
What were Phillips 66's latest quarterly results?
Phillips 66 reported revenue of $32.5 B and net profit of $0.2 B for the Mar 26 quarter. Revenue rose 6.9% and profit fell 58.5% year on year. Earnings per share were $0.51. The operating margin was 0.3%, 1.7 pp higher than a year earlier. — as of 5 August 2026.
What is Phillips 66's revenue?
Phillips 66 reported revenue of $32.5 B in the Mar 26 quarter, +6.9% year on year. For the full FY25 fiscal year, revenue was $132 B (−7.5%). Over the last 4 years revenue compounded at 4.4% a year. — as of 5 August 2026.
What is Phillips 66's profit?
Phillips 66 earned $0.2 B of net profit in the Mar 26 quarter, −58.5% year on year. Full-year FY25 profit was $4.5 B. The operating margin ran 0.3% in the latest quarter. — as of 5 August 2026.
What is Phillips 66's market cap?
Phillips 66's market capitalisation is $83.0 B at a stock price of $206. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Phillips 66's P/E ratio?
Phillips 66 trades at a P/E of 20.3×, at the 76th percentile of its own 4-year range, against a long-run median of 12.0×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Phillips 66 pay a dividend?
Yes — Phillips 66 declared $1.27 per share for Mar 26, and $4.87 per share across the last four reported quarters. The latest quarter is up 10.4% on the same quarter a year earlier. — as of 5 August 2026.
What is Phillips 66's dividend per share?
Phillips 66's most recently declared dividend is $1.27 per share for Mar 26, giving $4.87 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Phillips 66's dividend yield?
Phillips 66's trailing dividend yield is 2.37%: $4.87 declared per share across the last four reported quarters, against a share price of $206. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Phillips 66 overvalued?
On its own history, Phillips 66 looks expensive against its own history: its P/E of 20.3× sits at the 76th percentile of its 4-year range (long-run median 12.0×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is Phillips 66 growing?
Yes — Phillips 66 is growing: latest-quarter revenue +6.9% year on year, profit −58.5%, and the margin +1.7 pp at 0.3%. The 4-year compound rates are 4.4% (revenue) and 29.9% (profit). The earnings engine currently reads: improving — as of 5 August 2026.
How is Phillips 66 performing?
Phillips 66 is in a confirmed uptrend, 34 weeks in. Its latest quarter's revenue rose 6.9% and profit fell 58.5% year on year. Against the S&P 500 it has been ahead on a trailing-13-week view for 5 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Phillips 66 in?
Turning around — profit growth swung from −67.0% at the trough to +116.9%, a 4-quarter improving streak, ROCE holding at 1.2%. The read comes from the last 12 quarters of growth (revenue growth −2.4% latest, profit growth +116.9% latest, eps growth +131.2% latest) plus the ROCE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Phillips 66 in an uptrend?
Yes — the price is in a confirmed uptrend (week 34 of stage 2), trading +28.0% versus its 200-day average and at 93% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 5 August 2026.
Is Phillips 66 beating the market?
On recent form, yes — Phillips 66 has been ahead of the S&P 500 on a trailing-13-week view for 5 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.1 years the stock moved +175% against the S&P 500's +263% — behind the index over the full window. — as of 5 August 2026.
Will Phillips 66's stock price go up?
This page publishes no price forecast for Phillips 66. What it measures instead: the stock price is $206, the price is in a confirmed uptrend 34 weeks in. Its P/E of 20.3× sits at the 76th percentile of its own 4-year range. — as of 5 August 2026.
Is the market betting against Phillips 66?
No — short interest is 2.0% of Phillips 66's tradable float, about 2.6 days to cover at typical volumes. That is a low reading: the crowd is not positioned against this stock. With no quarter-by-quarter holder register here, short interest is the cleanest crowd read we hold — as of 5 August 2026.
Does Phillips 66 have too much debt?
It is moderate — Phillips 66's debt-to-equity is 0.91. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is Phillips 66's capex?
Phillips 66 spent $6.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $2.2 B. — as of 5 August 2026.
What is Phillips 66's cash flow?
Phillips 66 generated $5.0 B of operating cash flow in FY25 and $2.7 B of free cash flow after $2.2 B of capital spending. Reported profit that year was $4.5 B, so operating cash ran ahead of profit. — as of 5 August 2026.
Is Phillips 66's profit real cash?
Yes — over the last 3 fiscal years, 116% of Phillips 66's reported profit arrived as operating cash. In FY25, operating cash was $5.0 B against reported profit of $4.5 B. The cash then goes mostly into building capacity. Cash-flow resolution is annual — as of 5 August 2026.
How financially safe is Phillips 66?
On the balance sheet, the Z-score reads 2.97 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That is in the grey band — neither clearly safe nor clearly distressed. — as of 5 August 2026.
Where is Phillips 66 in its business cycle?
Phillips 66's FY25 operating margin was 1.8%, against a 5-year band of −0.9%–5.6%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 0.3%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Phillips 66 story?
The sharpest disagreement: annual EPS moved +116.2% against a +72.1% price move — the market has not yet caught up with the delivery. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Phillips 66 a stock worth studying right now?
This is not investment advice. The machine read: Phillips 66's earnings have outrun its stock. EPS grew +116.2% in a year against a +72.1% price move. The sharpest open question: whether the price catches up with earnings that have already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.